196 related articles for article (PubMed ID: 31839526)
1. Systematic review of management of gallbladder disease in patients undergoing minimally invasive bariatric surgery.
Leyva-Alvizo A; Arredondo-Saldaña G; Leal-Isla-Flores V; Romanelli J; Sudan R; Gibbs KE; Petrick A; Soriano IS;
Surg Obes Relat Dis; 2020 Jan; 16(1):158-164. PubMed ID: 31839526
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial.
Haal S; Guman MSS; Boerlage TCC; Acherman YIZ; de Brauw LM; Bruin S; de Castro SMM; van Hooft JE; van de Laar AWJM; Moes DE; Schouten M; Schouten R; van Soest EJ; van Veen RN; de Vries CEE; Fockens P; Dijkgraaf MGW; Gerdes VEA; Voermans RP
Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):993-1001. PubMed ID: 34715031
[TBL] [Abstract][Full Text] [Related]
3. Gallbladder management in obesity surgery.
Mason EE; Renquist KE
Obes Surg; 2002 Apr; 12(2):222-9. PubMed ID: 11975217
[TBL] [Abstract][Full Text] [Related]
4. A Prospective Study of the Conservative Management of Asymptomatic Preoperative and Postoperative Gallbladder Disease in Bariatric Surgery.
Pineda O; Maydón HG; Amado M; Sepúlveda EM; Guilbert L; Espinosa O; Zerrweck C
Obes Surg; 2017 Jan; 27(1):148-153. PubMed ID: 27324135
[TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial).
Boerlage TCC; Haal S; Maurits de Brauw L; Acherman YIZ; Bruin S; van de Laar AWJM; Moes DE; van Wagensveld BA; de Vries CEE; van Veen R; Schouten R; Dijkgraaf MG; Fockens P; Gerdes VEA; Voermans RP
BMC Gastroenterol; 2017 Dec; 17(1):164. PubMed ID: 29262795
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Cholelithiasis and Choledocholithiasis in Morbidly Obese South Indian Patients and the Further Development of Biliary Calculus Disease After Sleeve Gastrectomy, Gastric Bypass and Mini Gastric Bypass.
Mishra T; Lakshmi KK; Peddi KK
Obes Surg; 2016 Oct; 26(10):2411-7. PubMed ID: 26910024
[TBL] [Abstract][Full Text] [Related]
7. Elective cholecystectomy after Roux-en-Y gastric bypass: why should asymptomatic gallstones be treated differently in morbidly obese patients?
Swartz DE; Felix EL
Surg Obes Relat Dis; 2005; 1(6):555-60. PubMed ID: 16925290
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholic Acid for 6 Months After Bariatric Surgery Is Impacting Gallstone Associated Morbidity in Patients with Preoperative Asymptomatic Gallstones.
Della Penna A; Lange J; Hilbert J; Archid R; Königsrainer A; Quante M
Obes Surg; 2019 Apr; 29(4):1216-1221. PubMed ID: 30604076
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Ursodeoxycholic Acid in the Prevention of Cholelithiasis After Sleeve Gastrectomy.
Coupaye M; Calabrese D; Sami O; Siauve N; Ledoux S
Obes Surg; 2019 Aug; 29(8):2464-2469. PubMed ID: 30945151
[TBL] [Abstract][Full Text] [Related]
10. Routine gallbladder screening not necessary in patients undergoing laparoscopic Roux-en-Y gastric bypass.
Papasavas PK; Gagné DJ; Ceppa FA; Caushaj PF
Surg Obes Relat Dis; 2006; 2(1):41-6; discussion 46-7. PubMed ID: 16925315
[TBL] [Abstract][Full Text] [Related]
11. [Gallbladder complications after bariatric surgery].
Veyrie N; Servajean S; Berger N; Loire P; Basdevant A; Bouillot JL
Gastroenterol Clin Biol; 2007 Apr; 31(4):378-84. PubMed ID: 17483774
[TBL] [Abstract][Full Text] [Related]
12. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study.
Wudel LJ; Wright JK; Debelak JP; Allos TM; Shyr Y; Chapman WC
J Surg Res; 2002 Jan; 102(1):50-6. PubMed ID: 11792152
[TBL] [Abstract][Full Text] [Related]
13. Retrospective review of the preoperative biliary and gastrointestinal evaluation for gastric bypass surgery.
Vanek VW; Catania M; Triveri K; Woodruff RW
Surg Obes Relat Dis; 2006; 2(1):17-22; discussioon 22-3. PubMed ID: 16925307
[TBL] [Abstract][Full Text] [Related]
14. Management of gallstones and gallbladder disease in patients undergoing gastric bypass.
Quesada BM; Kohan G; Roff HE; Canullán CM; Chiappetta Porras LT
World J Gastroenterol; 2010 May; 16(17):2075-9. PubMed ID: 20440847
[TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: statistical analysis plan for a randomised controlled trial (UPGRADE trial).
Haal S; Guman MSS; de Brauw LM; van Veen RN; Schouten R; Fockens P; Gerdes VEA; Dijkgraaf MGW; Voermans RP
Trials; 2020 Jul; 21(1):676. PubMed ID: 32703246
[TBL] [Abstract][Full Text] [Related]
16. Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: a meta-analysis.
Uy MC; Talingdan-Te MC; Espinosa WZ; Daez ML; Ong JP
Obes Surg; 2008 Dec; 18(12):1532-8. PubMed ID: 18574646
[TBL] [Abstract][Full Text] [Related]
17. Predictive Factors of Cholelithiasis After Prophylactic Administration of Ursodeoxycholic Acid Following Laparoscopic Bariatric Surgery: Tehran Obesity Treatment Study.
Barzin M; Andalib A; Khalaj A; Mahdavi M; Valizadeh M; Mousapour P; Hosseinpanah F
Obes Surg; 2022 Feb; 32(2):311-317. PubMed ID: 34816356
[TBL] [Abstract][Full Text] [Related]
18. Bariatric emergencies: what the general surgeon should know.
Boru C; Silecchia G
Chirurgia (Bucur); 2010; 105(4):455-64. PubMed ID: 20941965
[TBL] [Abstract][Full Text] [Related]
19. Effect of oral ursodeoxycholic acid on cholelithiasis following laparoscopic sleeve gastrectomy for morbid obesity.
Nabil TM; Khalil AH; Gamal K
Surg Obes Relat Dis; 2019 Jun; 15(6):827-831. PubMed ID: 31113752
[TBL] [Abstract][Full Text] [Related]
20. Is Concomitant Cholecystectomy Necessary for Asymptomatic Cholelithiasis During Laparoscopic Sleeve Gastrectomy?
Yardimci S; Coskun M; Demircioglu S; Erdim A; Cingi A
Obes Surg; 2018 Feb; 28(2):469-473. PubMed ID: 28803397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
